Flex Pharma's FLX-787 shows treatment effect in MS patients with cramps/spasms in exploratory study; shares up 6% [Seeking Alpha]
FLEX PHARMA (FLKS)
Last flex pharma earnings: 8/1 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.flex-pharma.com/investor-overview
Company Research
Source: Seeking Alpha
Flex Pharma's FLX-787 shows treatment effect in MS patients with cramps/spasms in exploratory study; shares up 6%An exploratory Phase 2 studyevaluating Flex Pharma's (FLKS+5.5%) FLX-787 in multiple sclerosis (MS) patients with frequent muscle cramps/spasms and spasticity showed a treatment effect.Results showed a 27.3% reduction in the frequency of cramps/spasms compared to control (p=0.001). Patients in the treatment group also experienced a 1.4-day increase cramp/spasm-free days per 14-day period compared to control (p=0.0457).FLX-787 was generally well-tolerated with no serious drug-related adverse events reported. GI-related adverse events reported were diarrhea and nausea.The results will be submitted for presentation at future medical conferences.The company says it plans to advance the candidate into a formal Phase 2b study for the indication.Flex describes FLX-787 as atransient receptor potential ion channelactivator, specifically a co-activator of the proteins TRPA1 and TRPV1
Show less
Read more
Impact Snapshot
Event Time:
FLKS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLKS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLKS alerts
High impacting FLEX PHARMA news events
Weekly update
A roundup of the hottest topics